Skip to main content
All Events
Date

July 25, 2024

Time

8:00am EDT

3:00pm EAT

5:30pm IST

Related Topics
PostpartumPostpartum Hemorrhage (PPH)
Subscribe to our Newsletter
Share

Uterotonic medications are critical tools for preventing and treating postpartum hemorrhage, a leading cause of maternal mortality. Some uterotonic medications can also be used to start or strengthen labor but require considerable safeguards to avoid any negative health effects for the fetus.  Join MOMENTUM on Thursday, July 25 from 8:00-9:00 a.m. EDT/ 3:00-4:00 p.m. EAT/ 5:30-6:30 IST for a webinar exploring strategies, efforts and tools related to optimizing uterotonic use to improve childbirth outcomes. Presentations will explore uterotonic use for labor induction and augmentation, with a focus on practices in India and South Asia, and new efforts to prevent postpartum hemorrhage, including findings from a global survey of national programs and a proposed evaluation strategy related to heat-stable carbetocin for Madagascar. Following presentations, participants will have the opportunity to engage with experts during a Q&A session. Live interpretation in French will be available.

Related Resources

See All Resources

Journal Article

Sep 19, 2024

Maternal | Morbidity

Incidence, Causes and Outcomes of Postpartum Hemorrhage in Eastern Ethiopia: A Multicenter Surveillance Study

Guidance

Dec 21, 2023

AMTSL (Active Management of Third Stage of Labor) | Complications

WHO recommendations on the assessment of postpartum blood loss and use of a treatment bundle for postpartum haemorrhage

Journal Article

Dec 6, 2023

Antenatal Care (ANC) | Postpartum

Vulnerabilities and reparative strategies during pregnancy, childbirth, and the postpartum period: moving from rhetoric to action

Journal Article

Dec 6, 2023

Postnatal Care (PNC) | Morbidity

Postnatal morbidity: prevalent, enduring, and neglected